ClinConnect ClinConnect Logo
Search / Trial NCT06373926

Evaluation of Cell Membrane Expression of Annexin A2 on Monocytes by Flow Cytometry in Primary Antiphospholipid Syndrome

Launched by CENTRE HOSPITALIER UNIVERSITAIRE, AMIENS · Apr 16, 2024

Trial Information

Current as of July 24, 2025

Recruiting

Keywords

Annexin A2 Antiphospholipid Syndrome Monocytes

ClinConnect Summary

This clinical trial is studying a protein called Annexin A2 (ANXA2) and its role in a condition known as Antiphospholipid Syndrome (APS). APS can lead to blood clots and other serious complications. Researchers want to see how much ANXA2 is present on certain immune cells in patients with APS. Understanding this could help explain some of the problems related to APS and potentially lead to better treatments.

To participate in the trial, you must be an adult (18 years or older) diagnosed with APS according to specific medical guidelines. Unfortunately, people with certain other health issues, such as cancers or other autoimmune diseases, cannot join. If you are eligible and decide to participate, you can expect to have your blood tested to measure the levels of ANXA2 on your immune cells. This research is important because it may reveal new ways that APS affects the body, which could eventually help improve care for patients with this condition.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • APS patients who fulfilled the revised criteria for APS
  • Exclusion Criteria:
  • Patients less than 18 years old
  • Solid and hematological malignancies
  • Other autoimmune diseases
  • Cirrhosis

About Centre Hospitalier Universitaire, Amiens

The Centre Hospitalier Universitaire (CHU) Amiens is a leading academic medical center in France dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on multidisciplinary collaboration, CHU Amiens integrates patient care, education, and research to enhance treatment outcomes and improve patient quality of life. The institution is committed to ethical standards and regulatory compliance in its clinical research endeavors, aiming to contribute significantly to the medical community and the development of new therapeutic approaches. By fostering partnerships with various stakeholders, CHU Amiens strives to translate scientific discoveries into practical applications that benefit patients and healthcare systems alike.

Locations

Amiens, , France

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported